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background:  We sought to examine the relationship between transfusion of packed red blood cells (PRBC) and the risk of morbidity and mortality 
after isolated aortic valve replacement (AVR).
methods:  A retrospective single-center study was performed including 2169 patients undergoing AVR from 2000-2012. Patients were 
dichotomized according to the number of PRBC transfusion at operation. Long-term survival and logistic regression model predicting transfusion as 
potential risk factor for mortality were analyzed.
results:  Mean follow-up duration was 4.9±3.5 years. Of all patients, 1480 (68.2%) received no PRBC, 472 (21.8%) received 1-2 units of PRBC, 
and 217 (10%) received 3 or more units. When compared to expected survival, survival of patients not receiving any PRBC was better, while 
patients receiving any amount of PRBC units showed decreased survival (log-rank p<0.001). Transfusion of 1 or 2 units of PRBC was associated with 
decreased long-term survival (hazard ratio [HR], 1.53; p = 0.001). The association between transfusion and mortality was increased with 3 or more 
units of PRBC transfusion ([HR], 1.69; p < 0.001).
conclusions:  Transfusion of PRBC is an independent, dose-dependent risk factor for overall mortality after AVR. Preoperative optimization of 
anemia is warranted.
 
